EP2486051
Lyfjasamsetning sem inniheldur endurraðað hCG
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
4.10.2010EP published:
25.3.2020EP application number:
10763000.6
EP translation filed:
23.6.2020Grant published:
15.7.2020EPO information:
European Patent Register
Max expiry date:
3.10.2030Expiry date:
3.10.2025Next due date:
31.10.2025
Title:
PHARMACEUTICAL PREPARATION COMPRISING RECOMBINANT HCG
Timeline
Today
4.10.2010EP application
25.3.2020EP Publication
23.6.2020Translation submitted
15.7.2020Registration published
3.10.2025Expires
Owner
Name:
Ferring B.V.Address:
Polaris Avenue 144, 2132 JX Hoofddorp, NL
Inventor
Name:
COTTINGHAM, IanAddress:
CH-1162 St Prex, CH
Name:
PLAKSIN, DanielAddress:
CH-1162 St Prex, CH
Name:
WHITE, Richard, BoydAddress:
San Diego, CA 92103, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
09252360Date:
5.10.2009Country:
EP
Classification
Categories:
C07K 14/59, A61K 38/24
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 22.10.2020
Expires: 3.10.2021
Payer: Árnason Faktor ehf.
Number: 12
Paid: 27.10.2021
Expires: 3.10.2022
Payer: Árnason Faktor ehf.
Number: 13
Paid: 27.10.2022
Expires: 3.10.2023
Payer: Árnason Faktor ehf.
Number: 14
Paid: 31.10.2023
Expires: 3.10.2024
Payer: Árnason Faktor ehf.
Number: 15
Paid: 25.10.2024
Expires: 3.10.2025
Payer: Árnason Faktor ehf.